PAG
MRNA icon

Private Advisor Group’s Moderna MRNA Stock Holding History

Private Advisor Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.14K Buy
+600
New +$28K ﹤0.01% 2664
2021
Q1 		– Sell
-1,000
Closed -$3K – 1941
2020
Q4 		$3K Buy
+1,000
New +$101K ﹤0.01% 1769

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Private Advisor Group's MRNA Position: Q1 2026 in Review

Private Advisor Group reduced its Moderna (MRNA) stake by 31% in Q1 2026, selling an estimated $146K and leaving 6,812 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

Private Advisor Group first reported a position in MRNA in Q1 2020 and has held it in 25 quarters since. The position peaked at $14.2M in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Private Advisor Group held 6,812 shares of Moderna worth $346K as of Q1 2026.
  • Private Advisor Group sold 3,130 Moderna shares in Q1 2026, an estimated $146K.
  • Moderna made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #2096 holding.
  • Private Advisor Group first reported a position in Moderna in Q1 2020 and has held it in 25 quarters since.
  • Private Advisor Group's Moderna position peaked at $14.2M in Q3 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.